Order Article Reprints

Abdul-Mutakabbir JC, Kebriaei R, Stamper KC, Sheikh Z, Maassen PT, Lev KL, Rybak MJ. Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model. Antibiotics. 2020; 9(10):696. https://doi.org/10.3390/antibiotics9100696

Abdul-Mutakabbir, Jacinda C., Razieh Kebriaei, Kyle C. Stamper, Zain Sheikh, Philip T. Maassen, Katherine L. Lev, and Michael J. Rybak. 2020. "Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model" Antibiotics 9, no. 10: 696. https://doi.org/10.3390/antibiotics9100696

Abdul-Mutakabbir, J. C., Kebriaei, R., Stamper, K. C., Sheikh, Z., Maassen, P. T., Lev, K. L., & Rybak, M. J. (2020). Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model. Antibiotics, 9(10), 696. https://doi.org/10.3390/antibiotics9100696